1 July 2025 false No description of principal activity Taxfiler 2024.6 11397028 business:PrivateLimitedCompanyLtd 2025-07-01 2026-06-30 11397028 2025-06-30 11397028 2025-07-01 2026-06-30 11397028 business:AuditExempt-NoAccountantsReport 2025-07-01 2026-06-30 11397028 business:FilletedAccounts 2025-07-01 2026-06-30 11397028 2026-06-30 11397028 business:Director1 2025-07-01 2026-06-30 11397028 business:RegisteredOffice 2025-07-01 2026-06-30 11397028 2025-06-30 11397028 core:WithinOneYear 2026-06-30 11397028 core:WithinOneYear 2025-06-30 11397028 core:ShareCapital core:PreviouslyStatedAmount 2026-06-30 11397028 core:ShareCapital core:PreviouslyStatedAmount 2025-06-30 11397028 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2026-06-30 11397028 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-06-30 11397028 core:PreviouslyStatedAmount 2026-06-30 11397028 core:PreviouslyStatedAmount 2025-06-30 11397028 business:SmallEntities 2025-07-01 2026-06-30 11397028 countries:EnglandWales 2025-07-01 2026-06-30 11397028 business:OrdinaryShareClass1 2025-07-01 2026-06-30 11397028 business:OrdinaryShareClass1 2024-07-01 2025-06-30 11397028 2024-07-01 2025-06-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 11397028 (England and Wales)
PHARMAKON LTD Unaudited accounts for the year ended 30 June 2026
PHARMAKON LTD Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
PHARMAKON LTD Company Information for the year ended 30 June 2026
Director
Mrs Marzieh Zare
Company Number
11397028 (England and Wales)
Registered Office
112 Loughborough House 2 Honour Gardens London RM8 2GJ ENGLAND
Accountants
Fabaci Financial Ltd 30 Ebbett Court Victoria Road London W3 6BW
- 3 -
PHARMAKON LTD Statement of financial position as at 30 June 2026
2026
2025
Notes
£
£
Current assets
Debtors
4
2,772
4,576
Cash at bank and in hand
4,280
4,043
7,052
8,619
Creditors: amounts falling due within one year
5
(6,845)
(8,257)
Net current assets
207
362
Net assets
207
362
Capital and reserves
Called up share capital
6
1
1
Profit and loss account
206
361
Shareholders' funds
207
362
For the year ending 30 June 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 6 August 2026 and were signed on its behalf by
Mrs Marzieh Zare Director Company Registration No. 11397028
- 4 -
PHARMAKON LTD Notes to the Accounts for the year ended 30 June 2026
1
Statutory information
PHARMAKON LTD is a private company, limited by shares, registered in England and Wales, registration number 11397028. The registered office is 112 Loughborough House, 2 Honour Gardens, London, RM8 2GJ, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in GBP sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.
4
Debtors
2026
2025
£
£
Amounts falling due within one year
Other debtors
2,772
4,576
5
Creditors: amounts falling due within one year
2026
2025
£
£
Taxes and social security
6,295
7,707
Accruals
550
550
6,845
8,257
6
Share capital
2026
2025
£
£
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1
1
- 5 -
PHARMAKON LTD Notes to the Accounts for the year ended 30 June 2026
7
Average number of employees
During the year the average number of employees was 1 (2025: 1).
- 6 -